Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04131621
Title Nivolumab/Ipilimumab in Second Line CUP-syndrome (CheCUP)
Acronym CheCUP
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors University Hospital Heidelberg
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
University of Heidelberg RECRUITING Heidelberg Germany Details
*Shaded cells indicate that there was no data available from for the field